Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01114516 · ClinicalTrials.gov registry record · NA
Multifactorial Approach to Emergent Cerclage
A NA study of Cervical Insufficiency, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT01114516 is a NA study of Cervical Insufficiency that has completed, run by Northwestern University. The registered enrollment target is 53 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01114516, a NA study of Cervical Insufficiency, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
Though cervical insufficiency is a common cause of second trimester pregnancy loss, the placement of an emergent cerclage in these patients is thought to improve perinatal outcomes. It is unknown whether the use of tocolytics and antibiotics prolongs pregnancies complicated by need for emergent cerclage. The objective is to determine whether administration of peri-operative antibiotics and indomethacin to patients receiving emergent cerclages for cervical insufficiency increases latency period to delivery compared with patients receiving emergent cerclage alone.
Conditions Studied
Interventions
- DRUG Indomethacin and antibiotics (cefazolin or clindamycin)
Study Locations (1)
Illinois
- Prentice Women's Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2010-03 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01114516
The ClinicalTrials.gov registry entry for NCT01114516 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervical Insufficiency appearing as the primary indexed condition, and to 1 intervention - of which Indomethacin and antibiotics (cefazolin or clindamycin) is the first listed.
NCT01114516 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01114516 about?
NCT01114516 is a clinical study titled "Multifactorial Approach to Emergent Cerclage". Though cervical insufficiency is a common cause of second trimester pregnancy loss, the placement of an emergent cerclage in these patients is thought to improve perinatal outcomes. It is unknown whether the use of tocolytics and antibiotics prolongs pregnancies complicated by need for emergent cerc...
What is the current status of trial NCT01114516?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2010-03. Estimated completion is 2014-03.
What conditions does trial NCT01114516 study?
This clinical trial studies the following conditions: Cervical Insufficiency.
What interventions are being tested in trial NCT01114516?
The interventions under investigation include: Indomethacin and antibiotics (cefazolin or clindamycin) (DRUG).
Who is sponsoring clinical trial NCT01114516?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01114516 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.